Literature DB >> 26294942

Previous Acute Polio and Post-Polio Syndrome: Recognizing the Pathophysiology for the Establishment of Rehabilitation Programs.

Marco Orsini1, Jano Alves de Souza2, Marco Antonio Araújo Leite2, Silmar Teixeira3, Arthur de Sá Ferreira4, Victor Hugo Bastos3, Marcos Rg de Freitas2, Acary Bulle Oliveira5.   

Abstract

Entities:  

Year:  2015        PMID: 26294942      PMCID: PMC4508541          DOI: 10.4081/ni.2015.5452

Source DB:  PubMed          Journal:  Neurol Int        ISSN: 2035-8385


× No keyword cloud information.
Previous acute poliomyelitis (PAP) can be defined as an endemic human disease caused by an enterovirus of worldwide distribution, which compromises the anterior horn cells of the spinal cord. Poliovirus has infected and victimized thousands of people all over the world. Only after the development of the inactivated virus vaccine by Jonas Salk, in 1955, and then with the attenuated virus vaccine, by Albert Bruce Sabin, in 1961, we saw a reduction in the number of poliomyelitis cases in the world.¹ The patients present clinical status characterized by muscle atrophy and paresis, especially in the lower limbs, under asymmetrical and disproportional form. There is a second form, bulbar, which compromises the motor neurons of the medulla, resulting in impairments in speech, swallowing and breathing. The purpose of this letter to the Editor is to alert readers about the risks of therapeutic exercise for this group of patients The pathophysiological framework related to the genesis of post-polio syndrome (PPS) is based on the theory of super training. Shortly after the episode of (PAP), the remaining motor neurons increase the number of sprouts (sproutings) for reinnervation of muscle fibers once denervated. Years after the acute episode, about three decades, there is a tendency to overload this system – that can be accelerated or attenuated depending on individual factors and especially the activities and/or therapeutic exercises carried out. In this case an intense metabolic demand in residual motor units occurs, triggering a process of secondary neuronal death. It is believed that 70% of patients victimized by PAP the will develop PPS.³ The PPS is marked by a new framework for amyotrophy, unusual fatigue, joint problems and pain – all of progressive character. The prevalence of fatigue is remarkably high, and may contribute significantly to patientsdisability and a poor quality of life. Other possible manifestations are: intolerance to cold and sleep apnea. We emphasize that, although there is a wide range of signs and symptoms, its totality is not expressed in all those affected.³ Aerobic training conducted at submaximal limits and muscle strengthening activities of low intensity have shown positive effects on muscle strength and cardio-respiratory system in patients with PPS. Therapeutic activities carried out in aquatic environments have a positive impact on pain and motor function. In patients with severe fatigue, it is recommended caution in the implementation of rehabilitation programs. Recognition of respiratory impairment and early introduction of non-invasive ventilatory aids prevent or delay further respiratory decline and the need for invasive respiratory aid. They must receive prophylactic treatment with antibiotics, immunization against flu and Pneumococcus and avoid smoking The management of patients by an interdisciplinary team is crucial for the establishment of goals in the short, medium and long term.[4] Today, the treatment of post-polio syndrome is based on non-pharmacological intervention, including lifestyle modification, joint protection, and the use of orthoses, adaptive equipment, or mobility aids that can reduce fatigue and preserve function. Decrease of physical activity, rest periods during the day and an individually tailored training program. Weight gain is to be avoided if at all possible in these patients, because increased weight only leads to further difficulty in the performance of daily activities.[4] Pain control may be difficult because it is usually generalized and not limited to a joint or limb. Simple physical procedures, such as heat, cold, massage and passive stretching may be very helpful; transcutaneous electrical nerve stimulation and acupuncture may also help in treatment. In 2009, a group of researchers of Neurology Service from the Federal University of São Paulo developed a bioceramic fabric, MIG3, a long infrared emitter. The researchers came to the conclusion that, over four weeks, it had significantly reduced complaints of pain and improved sleep quality. The radiation emitted by long infrared (LIR) fabrics increases membrane permeability and the calcium concentration in the cell membrane and cytoplasm; it biologically stimulates the cell, favoring the exchange of metabolites within the extracellular medium, nurturing the cell. It also acts on mitochondria, promoting the ATP synthesis used in muscular contraction.[5] There is no diagnostic test for PPS, and the diagnosis is based on a proper clinical workup where all other possible explanations for the new symptoms are ruled out. Intravenous immunoglobulin (IVIG) has been tried in some studies, all having positive results. IVIG could probably be a therapeutic alternative, but the potential benefit is modest and transitory.[6] We end this editorial indicating that many patients ask us about the real effects of therapeutic exercise in the minimization or reversibility of the decline of their functions. We show that, in the general population, physical activity is considered as an adjunct to a good health condition and psychological benefits, provided that it respects the particularities of patients and especially the pathophysiological framework of PPS.
  5 in total

Review 1.  [Post-polio syndrome. Part II. Therapeutic management].

Authors:  Ewa Matyja
Journal:  Neurol Neurochir Pol       Date:  2012 Jul-Aug       Impact factor: 1.621

2.  A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome.

Authors:  Laura Bertolasi; Emma Frasson; Mara Turri; Alberto Gajofatto; Monia Bordignon; Elisabetta Zanolin; Millo Martini; Fabiana Pimazzoni; Monica Ferlisi; Gianluigi Zanusso; Massimo Rossi; Salvatore Monaco
Journal:  J Neurol Sci       Date:  2013-05-15       Impact factor: 3.181

3.  Living with polio and postpolio syndrome in the United Kingdom.

Authors:  Anita Atwal; Amy Giles; Georgia Spiliotopoulou; Nicola Plastow; Lesley Wilson
Journal:  Scand J Caring Sci       Date:  2012-07-22

4.  [Polio paralytic. New problems: postpolio syndrome].

Authors:  Jesús Esteban
Journal:  Rev Esp Salud Publica       Date:  2013 Sep-Oct

5.  Effects of the use of MIG3 bioceramics fabrics use--long infrared emitter--in pain, intolerance to cold and periodic limb movements in post-polio syndrome.

Authors:  Tatiana Mesquita e Silva; Gustavo Antonio Moreira; Abrahão Augusto Juviniano Quadros; Márcia Pradella-Hallinan; Sergio Tufik; Acary Souza Bulle Oliveira
Journal:  Arq Neuropsiquiatr       Date:  2009-12       Impact factor: 1.420

  5 in total
  1 in total

1.  A twelve-week, four-arm, randomized, double-blind, placebo-controlled, phase 2 prospective clinical trial to evaluate the efficacy and safety of an anthroposophic multimodal treatment on chronic pain in outpatients with postpolio syndrome.

Authors:  Ricardo Ghelman; Ivete Y Akiyama; Valeria T de Souza; Jussara Falcão; Vera Orgolini; Jorge K Hosomi; Abrahão A J Quadros; Acary S B Oliveira
Journal:  Brain Behav       Date:  2020-03-11       Impact factor: 2.708

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.